Abstract:Purpose: This study aimed to investigate the characteristics of various pulmonary lesions as revealed by 68 Ga-FAPI PET/CT and to determine the utility of 68 Ga-FAPI PET/CT in distinguishing the nature of these pulmonary lesions. Methods: A retrospective analysis was conducted on 99 patients with pulmonary lesions, who were categorized into three distinct groups: primary lung tumors (G1), metastatic lung tumors (G2), and benign lesions (G3). Each participant underwent a 68 Ga-FAPI PET/CT scan. Among these groups, variables such as the Tumor/Background Ratio (TBR), Maximum Standardized Uptake Value (SUVmax), and the true positive rate of the lesions were compared. Furthermore, the FAPI uptake in nodular-like pulmonary lesions (d<3cm) and those with irregular borders was evaluated across the groups. A correlation analysis sought to understand the relationship between FAPI uptake in primary and pulmonary metastatic lesions. Results: The study's participants were composed of 52 males and 47 females, with an average age of 56.8 ± 13.2 years. A higher uptake and detection rate for pulmonary lesions were exhibited by Group G1 compared to the other groups (SUVmax [G1 vs. G2 vs. G3: 9.1 ± 4.1 vs. 6.1 ± 4.1 vs. 5.3 ± 5.8], P <0.05; TBR [G1 vs. G2 vs. G3: 6.2 ± 2.4 vs. 4.1 ± 2.2 vs. 3.2 ± 2.7], P <0.01; true positive rate 95.1% vs. 88% vs. 75.6%]. In nodular-like lung lesions smaller than 3 cm, G1 showed a significantly higher FAPI uptake compared to G2 and G3 (SUVmax [G1 vs. G2 vs. G3: 8.8 ± 4.3 vs. 5.2 ± 3.2 vs. 4.9 ± 6.1], P <0.01; TBR [G1 vs. G2 vs. G3: 5.7 ± 2.7 vs. 3.7 ± 2.1 vs. 3.3 ± 4.4], P <0.05). Both G1 and G2 demonstrated significantly elevated FAPI agent activity in irregular-bordered pulmonary lesions when compared to G3 (SUVmax [G1 vs. G2 vs. G3: 10.9 ± 3.3 vs. 8.5 ± 2.7 vs. 4.6 ± 2.7], P <0.01; TBR [G1 vs. G2 vs. G3: 7.2 ± 2.1 vs. 6.4 ± 1.3 vs. 3.2 ± 2.4], P <0.01). A positive correlation was identified between the level of 68 Ga-FAPI uptake in primary lesions and the uptake in pulmonary metastatic lesions within G2 (r=0.856, P <0.05). Conclusion: 68 Ga-FAPI PET/CT imaging proves to be of significant value in the evaluation of pulmonary lesions, offering distinctive insights into their nature.

Elevated 68 Ga-FAPI Activity in Klebsiella Pneumoniae Invasion Syndrome.

F-18 FDG Hypermetabolism in Mass-Forming Focal Pancreatitis and Old Hepatic Schistosomiasis with Granulomatous Inflammation Misdiagnosed by PET/CT Imaging.

Elevated 68Ga-FAPI Activity in Leiomyosarcoma

Elevated Uptake of 18F-FDG in PET/CT Imaging of a Nocardial Pleural Nodule

Elevated 68 Ga-FAPI Activity in Pulmonary Inflammatory Pseudotumor

68Ga-FAPI and 18F-FDG PET/CT Images in a Patient With Extrapulmonary Tuberculosis Mimicking Malignant Tumor

Hepatic Inflammatory Pseudotumor on 18F-FDG and 18F-FAP-42 PET/CT

18F-FAPI for Imaging Metastatic Perivascular Epithelioid Cell Neoplasm

68Ga-FAPI-04 PET/CT Imaging for Fibrous Dysplasia of the Bone

68Ga-FAPI-04 PET/CT Imaging of Mesenteric Aggressive Fibromatosis

68Ga-Fapi and 18F-PET/CT Images in Intestinal Tuberculosis.

Different Features of <SUP>18</SUP>F-FAPI, <SUP>18</SUP>F-FDG PET/CT and MRI in the Evaluation of Extrahepatic Metastases and Local Recurrent Hepatocellular Carcinoma (HCC): A Case Report and Review of the Literature

Elevated FAPI Activity in an Adult Brodie Abscess

Increased 68Ga-FAPI Uptake in Pulmonary Sclerosing Pneumocytoma

Increased 68 Ga-FAPI Uptake in Pulmonary Sclerosing Pneumocytoma

Increased 68Ga-Fapi Uptake by Mediastinal Benign Teratoma on 68Ga-Fapi PET/CT.

Positive 18F-FDG and Negative 68Ga-FAPI-04 Findings in a Patient With Gallbladder Adenocarcinoma

Clinical application of 68Ga-FAPI PET/CT in malignant tumors

A retrospective study of 68Ga-FAPI PET/CT in differentiating the nature of pulmonary lesions

Organizing Pneumonia With Intense 68Ga-FAPI Uptake Mimicking Lung Cancer on 68Ga-FAPI PET/CT

Comparison of 18F-FDG and 68Ga-FAPI PET/CT in a Rare Renal Leiomyoma